Global University Venturing

VC assets accounted for 19% of Yale’s endowment portfolio by June 2018 compared with 13.7% four years previously, as resources shifted away from leveraged buyouts and real estate.

Garwood Medical Devices is developing two therapeutic electrode-powered products based on licences from University of Buffalo, having last raised $3.6m in 2016.

MIT spinout Conduit was founded in 2017 to commercialise a decentralised cloud computing concept drawing upon the spare processing resources of IT clusters.

The Cambridge spinout plans to build out the business for its automated customer support platform after collecting $12m in series A funding.

Gyroscope Therapeutics recently commenced phase 1/2 clinical trials on a retinal gene therapy for dry age-related macular degeneration.

The seed capital will help UAB-founded TriAltus Bioscience commercialise its protein purification materials, which are already being used by research clients in the US, Brazil and EU.

UCSD-founded imaging technology developer Gojoya has collected cash from Intel Capital to pursue product development and recruitment.

Anaveon emerged out of University of Zurich in late 2017 with the support of Novartis-backed UZH Life Sciences Fund and the corporate has now also invested directly.

A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Pallares, a member of NMSU’s IP advisory committee, has become fund manager of the $1.9m Arrowhead Innovation Fund, which backs New Mexico-based startups.

Oregon Venture Fund and Rogue Venture Partners have both backed University of Oregon's DNA testing services provider NemaMetrix to bring the spinout’s total to $8.5m.